Raymond James & Associates’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,500
Closed -$211K 4145
2022
Q2
$211K Sell
5,500
-2,100
-28% -$1.05M ﹤0.01% 3481
2022
Q1
$416K Hold
7,600
﹤0.01% 3180
2021
Q4
$422K Buy
+7,600
New +$3.44M ﹤0.01% 3212
2021
Q3
Sell
-7,600
Closed -$206K 4266
2021
Q2
$206K Buy
+7,600
New +$3.03M ﹤0.01% 3670

Other funds holding UNH

Raymond James & Associates's UNH Position: Q3 2024 in Review

Raymond James & Associates increased its UnitedHealth (UNH) stake by 33% in Q3 2024, buying an estimated $332M and bringing the position to 2,361,396 shares worth $1.38B. The position accounts for 0.84% of the portfolio, ranked #15.

Raymond James & Associates first reported a position in UNH in Q2 2013 and has held it in 46 quarters since. 3,468 funds tracked by Wall St. Rank hold UNH as of Q3 2024.

  • Raymond James & Associates held 2,361,396 shares of UnitedHealth worth $1.38B as of Q3 2024.
  • Raymond James & Associates bought 587,088 UnitedHealth shares in Q3 2024, an estimated $332M.
  • UnitedHealth made up 0.84% of Raymond James & Associates's portfolio in Q3 2024, its #15 holding.
  • Raymond James & Associates first reported a position in UnitedHealth in Q2 2013 and has held it in 46 quarters since.
  • 3,468 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.